LLY

888.43

+1.19%↑

JNJ

242.55

+0.95%↑

ABBV

212.99

+1.58%↑

NVS

150.28

+1.37%↑

MRK

118.13

-1.3%↓

LLY

888.43

+1.19%↑

JNJ

242.55

+0.95%↑

ABBV

212.99

+1.58%↑

NVS

150.28

+1.37%↑

MRK

118.13

-1.3%↓

LLY

888.43

+1.19%↑

JNJ

242.55

+0.95%↑

ABBV

212.99

+1.58%↑

NVS

150.28

+1.37%↑

MRK

118.13

-1.3%↓

LLY

888.43

+1.19%↑

JNJ

242.55

+0.95%↑

ABBV

212.99

+1.58%↑

NVS

150.28

+1.37%↑

MRK

118.13

-1.3%↓

LLY

888.43

+1.19%↑

JNJ

242.55

+0.95%↑

ABBV

212.99

+1.58%↑

NVS

150.28

+1.37%↑

MRK

118.13

-1.3%↓

Strona główna・Stock List・Geron Corp

Geron Corp

Open

SectorHealthcare

1.4

Buy Sell

Overview

Share price change

24h

Current

Min

1.37

Max

1.42

Key metrics
By Trading Economics
Income	-10M -29M
Sales	788K 48M
EPS	-0.03
Profit margin	-60.11
Employees	258
EBITDA	-14M -24M

Recommendations
By TipRanks
Recommendations	Buy
12 Months Forecast	+132.14% upside

Dividends
By Dow Jones
Next Earnings	6 maj 2026

Market Stats
By TradingEconomics
Market Cap	-143M 986M
Previous open	1.4
Previous close	1.4

News Sentiment

By Acuity

38%

62%

111 / 349 Ranking in Healthcare

Geron Corp Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

27 mar 2026, 17:33 UTC

Major News Events

ECB Should Not Rush Its Response to Iran Conflict, Says Schnabel -- Update

27 mar 2026, 17:00 UTC

Major News Events

ECB Shouldn't Rush Its Response to Iran Conflict, Schnabel Says

27 mar 2026, 16:03 UTC

Major News Events

Fertilizer Maker Yara Warns Farmers Are Being Squeezed by Price Surge Amid War -- Commodities Roundup

29 mar 2026, 23:47 UTC

Market Talk

Major News Events

Gold Falls Amid Rising Inflation Fears -- Market Talk

29 mar 2026, 23:46 UTC

Market Talk

Major News Events

Nikkei May Fall on Fears About Shortage of Petrochemical Products -- Market Talk

29 mar 2026, 23:35 UTC

Market Talk

Major News Events

Oil Rises on Supply-Disruption Concerns Spurred by Widening Mideast Conflict -- Market Talk

29 mar 2026, 23:23 UTC

Market Talk

Australia's National Cabinet to Avoid Covid-Style Measures -- Market Talk

29 mar 2026, 22:34 UTC

Market Talk

Macroeconomic Tailwind for Warehouse Dissipates -- Market Talk

29 mar 2026, 22:09 UTC

Market Talk

Amplitude's Next Well "Effectively a Must-Win" for Growth Thesis -- Market Talk

29 mar 2026, 21:06 UTC

Market Talk

Major News Events

Australia's Economy Could Already Be Contracting Amid Oil Shock -- Market Talk

29 mar 2026, 21:03 UTC

Market Talk

Australia's Government Wants to Avoid Heavy Handed Oil Shock Response -- Market Talk

29 mar 2026, 21:01 UTC

Market Talk

Major News Events

Australian National Cabinet Meeting to Focus on Oil Supply -- Market Talk

29 mar 2026, 09:30 UTC

Acquisitions, Mergers, Takeovers

Food Mega-Mergers Hardly Ever Work. Could McCormick-Unilever Be Different? -- Heard on the Street -- WSJ

28 mar 2026, 08:20 UTC

Market Talk

Health Care Roundup: Market Talk

27 mar 2026, 20:50 UTC

Market Talk

Health Care Roundup: Market Talk

27 mar 2026, 19:16 UTC

Market Talk

Major News Events

Oil Futures Rise On Uncertainty Ahead of Weekend -- Market Talk

27 mar 2026, 19:07 UTC

Market Talk

U.S. Natural Gas Gains As April Contract Expires -- Market Talk

27 mar 2026, 19:04 UTC

Market Talk

Gold Rises But Can't Finish the Week Positive -- Market Talk

27 mar 2026, 19:03 UTC

Market Talk

Major News Events

Global Forex and Fixed Income Roundup: Market Talk

27 mar 2026, 19:02 UTC

Market Talk

Major News Events

Among Central Banks, Canada Has Room to Handle Oil Inflation -- Market Talk

27 mar 2026, 18:12 UTC

Market Talk

Foreign Fuels and Feedstocks to Get RINs Until 2028 -- Market Talk

27 mar 2026, 17:36 UTC

Major News Events

The Iran War and Oil Prices Bring Risk of Deeper Market Lows. There Are Echoes of 2008. -- Barrons.com

27 mar 2026, 17:34 UTC

Market Talk

Acquisitions, Mergers, Takeovers

Delivery Hero Shares Bounce as Stake-Sale Report Whets Investor Appetites -- Market Talk

27 mar 2026, 17:29 UTC

Market Talk

U.S. Oil Rig Count Falls By 5 to 409 -- Market Talk

27 mar 2026, 16:38 UTC

Market Talk

Carnival's Outlook Assumes Oil Prices Will Come Down -- Market Talk

27 mar 2026, 16:32 UTC

Market Talk

Major News Events

Chinese Exposure to Higher Energy Costs Seen as Limited -- Market Talk

27 mar 2026, 16:20 UTC

Market Talk

Health Care Roundup: Market Talk

27 mar 2026, 15:43 UTC

Market Talk

Major News Events

Hormuz Closure Sends Tanker Rates to Record Highs -- Market Talk

27 mar 2026, 15:25 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

27 mar 2026, 15:25 UTC

Market Talk

Swiss Franc Dented by Rising European Yields, SNB Intervention Threats -- Market Talk

Peer Comparison

Price change

Geron Corp Forecast

Price Target

By TipRanks

132.14% upside

12 Months Forecast

Average 3.25 USD 132.14%

High 5 USD

Low 1 USD

Based on 5 Wall Street analysts offering 12 month price targets forGeron Corp - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

5 ratings

Buy

Hold

Sell

Based on 5 analysts giving stock ratings to Geron Corp - Dist in the past 3 months.

Sentiment

By Acuity

111 / 349 Ranking in Healthcare

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Geron Corp

Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in myeloid hematologic malignancies for the treatment of low or intermediate-1 risk myelodysplastic syndromes and intermediate-2 or high-risk myelofibrosis. The company was incorporated in 1990 and is headquartered in Foster City, California.